HTGMQ (HTG Molecular Diagnostics) Long-Term Debt: $0.00 Mil (As of Mar. 2023)


HTGMQ HTG Molecular Diagnostics Inc HTGMQ
12 GF Score
Price $0.00
View Full Analysis

What is HTG Molecular Diagnostics Long-Term Debt?

HTG Molecular Diagnostics HTGMQ 12 Long-Term Debt is $0.00 Mil as of Mar. 2023. GuruFocus rates HTGMQ with a GF Score™ of 12/100.

HTG Molecular Diagnostics's Long-Term Debt for the quarter that ended in Mar. 2023 was $0.00 Mil.

HTG Molecular Diagnostics's quarterly Long-Term Debt declined from Sep. 2022 ($1.30 Mil) to Dec. 2022 ($0.00 Mil) but then stayed the same from Dec. 2022 ($0.00 Mil) to Mar. 2023 ($0.00 Mil).

HTG Molecular Diagnostics's annual Long-Term Debt declined from Dec. 2020 ($8.57 Mil) to Dec. 2021 ($5.18 Mil) and declined from Dec. 2021 ($5.18 Mil) to Dec. 2022 ($0.00 Mil).

HTG Molecular Diagnostics  (OTCPK:HTGMQ) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

HTG Molecular Diagnostics Long-Term Debt Related Terms

HTG Molecular Diagnostics Long-Term Debt Historical Data

* Premium members only.

The historical data trend for HTG Molecular Diagnostics's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HTG Molecular Diagnostics Long-Term Debt Chart

HTG Molecular Diagnostics Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.68 6.87 8.57 5.18 0.00

HTG Molecular Diagnostics Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.05 2.02 1.30 0.00 0.00
HTGMQ
12GF Score
HTG Molecular Diagnostics Inc HTGMQ
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of $0.00 Mil mean?
HTG Molecular Diagnostics (HTGMQ) has a Long-Term Debt of $0.00 Mil as of Mar. 2023.
Is HTG Molecular Diagnostics' Long-Term Debt too high?
HTG Molecular Diagnostics' current Long-Term Debt is $0.00 Mil. Overall, HTG Molecular Diagnostics has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does HTG Molecular Diagnostics' Long-Term Debt compare to ABMC and TMO?
HTG Molecular Diagnostics' Long-Term Debt of $0.00 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Medical Diagnostics & Research company?
A good Long-Term Debt depends on the Medical Diagnostics & Research industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. HTG Molecular Diagnostics's current Long-Term Debt is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HTG Molecular Diagnostics stock overvalued right now?
HTG Molecular Diagnostics (HTGMQ) has a current Long-Term Debt of $0.00 Mil. The current Long-Term Debt is $0.00 Mil. HTG Molecular Diagnostics' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For HTG Molecular Diagnostics (HTGMQ), the current Long-Term Debt is $0.00 Mil as of Mar. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

HTG Molecular Diagnostics Business Description

Address 3430 E. Global Loop, Tucson, AZ, USA, 85706
HTG Molecular Diagnostics Inc is a life science company whose mission is to advance precision medicine through its transcriptome-wide profiling and medicinal chemistry technologies. The company derives revenue from sales of its HTG EdgeSeq system and integrated next-generation sequencing-based HTG EdgeSeq research use only assays and from sample processing services performed in its VERI/O laboratory. The company operates in one segment and its customers and distributors are located in the United States and Europe.
12GF Score

Get the complete analysis for HTGMQ

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price